-
Epsilon-sarcoglycan is a single-pass transmembrane sarcoglycan-family
glycoprotein (~437 aa, ~47 kDa) with an extracellular N-terminus
(residues 1-317), a transmembrane helix (318-338), and a cytoplasmic
C-terminal tail (339-437); it is a membrane structural/signaling component
rather than an enzyme or transporter.
"Canonical descriptions indicate SGCE encodes a **single-pass transmembrane
protein** of ~**437 amino acids** (~47 kDa) with an **extracellular
N-terminus**, a single **transmembrane helix**, and a **cytoplasmic
C-terminal tail**; one review provides residue-level topology (extracellular
**1–317**, transmembrane **318–338**, intracellular **339–437**).
"
-
SGCE participates in DGC/DGC-like sarcoglycan subcomplexes; in the nervous
system brain complexes may include beta-, delta-, epsilon-, and
zeta-sarcoglycans with roles in synapse organization (GABAergic synapse
biology) and astrocyte/BBB functions such as aquaporin-4 localization.
"In neuronal contexts, SGCE is discussed as participating in **DGC-like
complexes** rather than the canonical muscle sarcolemma DGC alone. A 2024
review summarizes that brain complexes may include **β-, δ-, ε-, and
ζ-sarcoglycans**, with proposed roles spanning synapse-associated
organization (including GABAergic synapse biology) and astrocyte/BBB-related
functions (e.g., aquaporin-4 localization).
"
-
Brain-specific isoform epsilon-SG2 carries a PDZ-binding motif and a kinase
consensus phosphorylation site in its cytoplasmic region, suggesting
regulated synaptic protein-protein interactions; fractionation suggests
epsilon-SG1 is postsynaptic and epsilon-SG2 presynaptic.
"Functional motifs in brain-specific isoforms are proposed to enable synaptic
interactions: ε-SG2 is described as having a **PDZ-binding motif** in its
cytoplasmic region and a kinase consensus phosphorylation site, consistent
with regulated protein–protein interactions.
"
-
In iPSC-derived neurons, brain-specific epsilon-sarcoglycan localizes to the
membrane fraction and cell surface; disease missense variants impair surface
localization and proteasome inhibition does not restore membrane targeting,
indicating a trafficking/processing defect.
"In iPSC-derived cortical neurons, a missense variant produced ε-sarcoglycan
detectable in whole-cell lysates but not at the cell surface; proteasome
inhibition increased total protein but did not restore surface localization,
consistent with a **trafficking/processing defect** rather than simple loss
of abundance.
"
-
SGCE is maternally imprinted (maternal allele typically silenced) in ~95% of
cases, producing predominant paternal transmission and reduced penetrance on
maternal transmission; it is the major genetic cause of myoclonus-dystonia.
"Multiple recent and authoritative sources describe SGCE as **maternally
imprinted** (maternal allele typically silenced), producing predominant
paternal transmission and reduced penetrance with maternal transmission.
"
-
Outside neurology, SGCE has a noncanonical nuclear function in triple-negative
breast cancer: it can translocate to the nucleus, interact with Sp1, promote
FGF-BP1 transcription, and thereby activate FGF-FGFR signaling to promote
stemness - a context-dependent role distinct from its DGC structural role.
"The authors report that SGCE can translocate to the **nucleus**, interact
with **Sp1**, and promote transcription of **FGF-BP1**, which then activates
**FGF–FGFR signaling** to promote stemness-associated phenotypes.
"